Skip to content

Evaluating the effects of progesterone on neurologic outcome of the patients with severe traumatic brain injury

Evaluating the effects of progesterone on neurologic outcome of the patients with severe traumatic brain injury

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12607000545460
Enrollment
230
Registered
2007-10-23
Start date
2004-03-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose in this clinical study was to evaluate the effects of progesterone on functional outcome of the patients with severe head injury. Progesterone, a hormone, has steroidal, neuroactive and neurosteroidal action in the center neuronal system. Recently, neuroprotective effects of progesterone have been shown in a variety of animal models including ischemic and traumatic brain insults models. Post-injury administration of progesterone in head injury subjects confers significant protection against injury-induced cerebral edema and secondary neuronal death, promoting behavioral recovery.

Interventions

Progesterone were administered at 1.0mg/kg via intramuscular injection at admission immediately and then once per 12h for 5 consecutive days respectively.

Sponsors

the Affiliated Hospital, School of Medicine, Hangzhou Normal University
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

severe traumatic brain injury , Glasgow Coma Scale (GCS) score of 8 or less after resuscitation and stabilization and between the ages of 15 and 65 years were entered into the study.

Exclusion criteria

received any investigational drug; severe anoxic intracerebral damage or brain death; clinical condition was unstable; with pregnancy and female patients during lactation.

Outcome results

None listed

Source: ANZCTR · Data processed: Apr 5, 2026